PYME con sede en el Reino Unido busca urgentemente un socio médico con sede en la UE para unirse al consorcio Horizonte Europa

A UK based SME is developing advanced optical components for XR to reduce side effects like nausea and visual discomfort. Targeting Horizon Europe HORIZON-CL4-2025-03-HUMAN-14 (€5–6M), they seek EU partners in MedTech, clinical research, hospitals, or life sciences, specifically related to Ophthalmology research and testing. We are actively seeking to expand our consortium with partners from the health and life sciences sector who possess the capability to research and evaluate the impact of XR technology on visual impairments, including its potential therapeutic applications. We welcome expressions of interest from a wide range of organisations, including SMEs, research groups, universities, eye hospitals, clinical research organisations, mid-sized enterprises, and large corporations. 

Additionally, we are looking for partners across industries where XR technology can deliver transformative value, who are interested in integrating our proprietary optical chip technology into their end-use applications. Potential collaborators may come from any relevant sector—such as healthcare, automotive, education, entertainment, construction, defence, or manufacturing—and we welcome proposals from SMEs, academic institutions, research bodies, medium-sized companies, and large enterprises.

Deadline of the call is 2 October 2025.